Skip to main content
Equibles
LXRX logo

LXRX · Lexicon Pharmaceuticals, Inc.

Track LXRX — free

Use LXRX with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about LXRX

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$2.32 -0.02 (-0.85%) At close · Aug 14
Market Cap
$1.03B
Shares
444.96M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

Model estimate

Expected Aug 14 short interest

as of Aug 14
33,969,627 +3.5% vs reported
The latest estimate appears in the chart below. Official release expected Aug 25. Methodology
Short Squeeze Score
64/100
Short interest 7.4% of shares — P83 Days to cover 12.5 — P92 Price vs VWAP +0.8% — P52 Short-volume trend -12.2% — P14 Short interest change +0.3% — P59 Worst FTD 0.02% of shares — P50

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-07-31). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Interest History

    Settlement Date Current Position Previous Position Change Days to Cover
    2026-08-31 Scheduled
    FINRA publishes Sep 10
    		 — — — —
    2026-08-14 Scheduled
    FINRA publishes Aug 25
    		 — — — —
    2026-07-31 32,825,365 32,730,919 +94,446 12.46
    2026-07-15 32,730,919 30,784,601 +1,946,318 12.03
    2026-06-30 30,784,601 25,425,636 +5,358,965 4.44
    2026-06-15 25,425,636 26,206,147 -780,511 12.62
    2026-05-29 26,206,147 26,140,915 +65,232 13.74
    2026-05-15 26,140,915 23,857,393 +2,283,522 6.22
    2026-04-30 23,857,393 23,674,019 +183,374 13.59
    2026-04-15 23,674,019 22,932,295 +741,724 11.62
    2026-03-31 22,932,295 22,693,812 +238,483 9.07
    2026-03-13 22,693,812 23,139,559 -445,747 7.14
    2026-02-27 23,139,559 24,523,367 -1,383,808 12.65
    2026-02-13 24,523,367 24,583,755 -60,388 8.57
    2026-01-30 24,583,755 25,160,782 -577,027 4.69
    2026-01-15 25,160,782 23,660,410 +1,500,372 17.95
    2025-12-31 23,660,410 23,344,944 +315,466 12.34
    2025-12-15 23,344,944 24,226,907 -881,963 16.82
    2025-11-28 24,226,907 24,649,659 -422,752 16.97
    2025-11-14 24,649,659 27,704,594 -3,054,935 8.42
    2025-10-31 27,704,594 26,834,292 +870,302 16.50
    2025-10-15 26,834,292 27,299,898 -465,606 8.37
    2025-09-30 27,299,898 28,381,788 -1,081,890 9.50
    2025-09-15 28,381,788 28,842,583 -460,795 15.72
    2025-08-29 28,842,583 27,905,830 +936,753 19.49
    Showing 1–23 of 23 settlements
    Key facts CIK 1062822 CUSIP 528872302 13F (30d) 150 filings 149 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)